## Core Concept
Arsenic compounds have been utilized in the treatment of certain types of cancer, leveraging their ability to induce apoptosis and inhibit cell proliferation. The therapeutic application of arsenic is particularly noted in hematological malignancies.

## Why the Correct Answer is Right
Arsenic trioxide is specifically used in the treatment of **Acute Promyelocytic Leukemia (APL)**, a subtype of acute myeloid leukemia (AML). APL is characterized by the accumulation of immature granulocytes (promyelocytes) in the bone marrow and peripheral blood. Arsenic trioxide works by promoting the differentiation of these promyelocytes into mature cells and inducing apoptosis in the leukemic cells. This is achieved through various mechanisms, including the degradation of the promyelocytic leukemia protein (PML)-retinoic acid receptor-alpha (RARα) fusion protein, which is a hallmark of APL.

## Why Each Wrong Option is Incorrect
- **Option A:** While arsenic compounds have shown some efficacy in treating certain solid tumors, their primary and most established use in oncology is not for breast cancer.
- **Option B:** Similarly, there is limited evidence to suggest a significant role of arsenic compounds in the treatment of lung cancer.
- **Option C:** Although there might be some investigative work into the use of arsenic compounds for treating various types of cancer, their established use is specifically for APL.

## Clinical Pearl / High-Yield Fact
A key point to remember is that **Arsenic trioxide is a first-line treatment for Acute Promyelocytic Leukemia (APL)**, especially in cases that are resistant to or have relapsed from standard therapies. This treatment has significantly improved the outcomes for patients with APL.

## Correct Answer Line
**Correct Answer: D. Acute Promyelocytic Leukemia.**